Current filters:  
United States
Buchanan Ingersoll & Rooney PC
COVID-19 has impacted the daily operations of life sciences companies in fundamental ways. It has also forced these companies to evaluate their financial stability and goals
Reed Smith
In the ever-extending period of working from home and social distancing, we have spent some time watching various exemplars of the "superhero"...
Shipman & Goodwin LLP
On Wednesday, the Supreme Court upheld two Trump administration rules that grant religious and moral exemptions to the Affordable Care Act's (ACA) requirement that employers...
Duane Morris LLP
On June 29, 2020, the U.S. Food & Drug Administration (FDA) issued guidance on how it will implement certain inspection procedures for device establishments—facilities where medical devices are manufactured.
Smith Gambrell & Russell LLP
In a 7-2 decision, the U.S Supreme Court upheld a Trump administration rule allowing employers to opt out of providing contraceptive coverage in their group health plans on moral or religious grounds.
Dickinson Wright PLLC
On June 19, 2020, the Department of Health and Human Services ("HHS") released its final rule (the "Final Rule") revising its enforcement of Section 1557 of the Patient Protection...
Sheppard Mullin Richter & Hampton
While traditionally healthcare businesses have tended to look to patent protection, it would behoove them to also think about trade secret protection to protect their valuable inventions.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
In Genentech, Inc. v. Immunex R.I. Corp., No. 2019-2155 (Fed. Cir. July 6, 2020), the Federal Circuit held that supplements to an FDA approved biologics license application do not trigger...
Reed Smith
The recent decision in Mize v. Mentor Worldwide LLC, ___ Cal. Rptr.3d ___, 2020 WL 3602482 (Cal. App. July 2, 2020)
Foley & Lardner
The National Institutes of Health recently opened its data platform for user feedback of its "All of Us Researcher Workbench."
Foley Hoag LLP
Last month, we described the announcement by the Department of Health and Human Services (HHS) announcing the allocation to Medicaid providers under the Coronavirus Aid, Relief, and...
Foley & Lardner
As previously reported in our August 16, 2019 and February 18, 2020 blogs, the Florida Patient Brokering Act (Florida PBA) was amended on July 1, 2019.
Reed Smith
We haven't see too many of these. The reason for that is the gadolinium litigation is practically a textbook example of where federal law ought to preempt state-law product liability claims...
Sheppard Mullin Richter & Hampton
In a June 23, 2020 decision, Judge Nichol of the United States District Court for the District of Columbia ruled in favor of the Center for Medicare and Medicaid Services ("CMS") and against the...
Cadwalader, Wickersham & Taft LLP
A biopharmaceutical company settled SEC charges for Foreign Corrupt Practices Act bribery and books and records violations.
Wolf, Greenfield & Sacks, P.C.
An Expert View from Jonathan Roses, counsel, Wolf, Greenfield & Sacks, and Toby Simpson, partner, Hoffmann…
Reed Smith
On many occasions, we've remarked that in modern prescription medical product liability litigation MDLs, the main objective of both plaintiffs and their counsel is to file as many lawsuits as possible.
Foley Hoag LLP
My colleague Ross Margulies has already told our readers about a provision of the new proposed Medicaid regulation governing how the program pays for outpatient ...
Reed Smith
Not long ago, an EPL (evil plaintiff lawyer) relayed to us that, based on reading our posts, another EPL had assumed we had a particular political view.
Reed Smith
One recent night, three-plus months into our ongoing solitary confinement, we found ourselves laughing very hard at a classic Road Runner cartoon.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Upcoming Events
Font Size:
Mondaq Social Media